Medical Properties Trust came into this Q3 2026 report as a deeply discounted hospital landlord with a troubled reputation and a stock that had already fallen sharply over the past quarter. The headline this time is simple. Normalized funds from operations, the key cash earnings metric for a real estate investment trust, landed at US$0.11 per share.
The market did not cheer. Shares dropped about 8% on the first trading day after the release, pulling the price near US$2.25. That move signals fresh doubt about whether the recent balance sheet repair and interest burden can support the current valuation.
Concerned that Medical Properties Trust looks cheap for a reason and want hospital real estate style income with stronger balance sheets…






